Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption
1. 99% of Series C Preferred shares redeemed or converted by investors. 2. Series D shares reduced by 68.5%, limiting future dilution. 3. BNB coin surged over 17% post crypto treasury announcement. 4. Windtree set to invest up to $700 million in BNB acquisitions. 5. Stockholder approval is required for continued treasury strategy.